Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Arlington, TX · Cypress, TX · Dallas, TX · +119 more sites
8 recruiting psoriasis studies with a site in Dallas, TX.
Sponsor: Bristol-Myers Squibb
Arlington, TX · Cypress, TX · Dallas, TX · +119 more sites
Sponsor: National Cancer Institute (NCI)
Dallas, TX · Fort Worth, TX · +48 more sites
Sponsor: Modern Research Associates, PLLC
Dallas, TX
Sponsor: Janssen Research & Development, LLC
Dallas, TX · Frisco, TX · Harlingen, TX · +22 more sites
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · Houston, TX · +36 more sites
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
Sponsor: Duke University
Dallas, TX · Houston, TX · +73 more sites
Sponsor: LAPIX Therapeutics Inc.
Dallas, TX · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.